{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T17:58:12Z","timestamp":1785002292144,"version":"3.55.0"},"reference-count":71,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,5,18]],"date-time":"2017-05-18T00:00:00Z","timestamp":1495065600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014588","name":"Sanofi Pasteur","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100014588","id-type":"DOI","asserted-by":"crossref"}]},{"name":"National Institute for Health Research Health Protection Research Unit"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.jinf.2017.04.007","type":"journal-article","created":{"date-parts":[[2017,4,25]],"date-time":"2017-04-25T15:33:08Z","timestamp":1493134388000},"page":"1-11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":63,"title":["Meningococcal disease in the Middle East and Africa: Findings and updates from the Global Meningococcal Initiative"],"prefix":"10.1016","volume":"75","author":[{"given":"Ray","family":"Borrow","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique A.","family":"Caugant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet","family":"Ceyhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Christensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ener Cagri","family":"Dinleyici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie","family":"Findlow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Glennie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Von Gottberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amel","family":"Kechrid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio","family":"V\u00e1zquez Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aziza","family":"Razki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhamed-Kheir","family":"Taha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassiba","family":"Tali-Maamar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalid","family":"Zerouali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jinf.2017.04.007_bib1","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.jinf.2016.01.007","article-title":"The UK joint specialist societies guideline on the diagnosis and management of acute meningitis and meningococcal sepsis in immunocompetent adults","volume":"72","author":"McGill","year":"2016","journal-title":"J Infect"},{"issue":"40","key":"10.1016\/j.jinf.2017.04.007_bib2","first-page":"331","article-title":"Meningococcal vaccines: polysaccharide and polysaccharide conjugate vaccines","volume":"77","author":"World Health Organization","year":"2002","journal-title":"Wkly Epidemiol Rec"},{"issue":"12","key":"10.1016\/j.jinf.2017.04.007_bib3","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.4161\/hv.21794","article-title":"Meningococcal serogroup Y emergence in Europe: update 2011","volume":"8","author":"Broker","year":"2012","journal-title":"Hum Vaccin Immunother"},{"issue":"48","key":"10.1016\/j.jinf.2017.04.007_bib4","doi-asserted-by":"crossref","first-page":"5855","DOI":"10.1016\/j.vaccine.2016.10.022","article-title":"Meningococcal disease in the Asia-Pacific region: findings and recommendations from the Global Meningococcal Initiative","volume":"34","author":"Borrow","year":"2016","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.jinf.2017.04.007_bib5","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1136\/adc.85.1.6","article-title":"Neurodevelopmental outcome in meningococcal disease: a case-control study","volume":"85","author":"Fellick","year":"2001","journal-title":"Arch Dis Child"},{"issue":"5","key":"10.1016\/j.jinf.2017.04.007_bib6","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1086\/322587","article-title":"Complications of meningococcal disease in college students","volume":"33","author":"Erickson","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2017.04.007_bib7","series-title":"Active bacterial core surveillance report, emerging infections program network, Neisseria meningitidis","author":"CDC","year":"2014"},{"key":"10.1016\/j.jinf.2017.04.007_bib8","first-page":"1","article-title":"The Global Meningococcal Initiative: global epidemiology, the impact of vaccines on meningococcal disease and the importance of herd protection","author":"Borrow","year":"2016","journal-title":"Expert Rev Vaccines"},{"issue":"Suppl 5","key":"10.1016\/j.jinf.2017.04.007_bib9","doi-asserted-by":"crossref","first-page":"S410","DOI":"10.1093\/cid\/civ597","article-title":"Meningococcal meningitis surveillance in the African meningitis belt, 2004-2013","volume":"61","author":"Lingani","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2017.04.007_bib10","series-title":"Weekly feedback bulletin on cerebrospinal meningitis: West Africa, weeks 48-52","author":"World Health Organization","year":"2016"},{"key":"10.1016\/j.jinf.2017.04.007_bib11","series-title":"Vaccines","first-page":"959","article-title":"Meningococcal vaccines","author":"Granoff","year":"2003"},{"key":"10.1016\/j.jinf.2017.04.007_bib12","series-title":"Meningococcal: meningococcal meningitis and septicaemia notifiable","first-page":"1","author":"Public Health England","year":"2016"},{"issue":"10061","key":"10.1016\/j.jinf.2017.04.007_bib13","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1016\/S0140-6736(16)31921-3","article-title":"Effectiveness and impact of a reduced infant schedule of 4CMenB vaccine against group B meningococcal disease in England: a national observational cohort study","volume":"388","author":"Parikh","year":"2016","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.jinf.2017.04.007_bib14","doi-asserted-by":"crossref","first-page":"e574","DOI":"10.1016\/j.ijid.2012.03.011","article-title":"Meningococcal disease in the Middle East and North Africa: an important public health consideration that requires further attention","volume":"16","author":"Ceyhan","year":"2012","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.jinf.2017.04.007_bib15","series-title":"Presented at: 36\u00e8me R\u00e9union Interdisciplinaire de Chimioth\u00e9rapie Anti Infectieuse","article-title":"Invasive meningococcal disease: surveillance in Casablanca (Morocco)","author":"Razki","year":"2016"},{"key":"10.1016\/j.jinf.2017.04.007_bib16","first-page":"1","article-title":"Situation epidemiologique de l'annee 2012","volume":"23","author":"Algerie","year":"2012","journal-title":"Relev Epid\u00e9miol Mens"},{"key":"10.1016\/j.jinf.2017.04.007_bib17","unstructured":"World Health Organization. Immunization standards \u2013 MenAfriVac: Meningococcal A conjugate 10 dose presentation. WHO web site. Available at: http:\/\/www.who.int\/immunization_standards\/vaccine_quality\/PQ_197_MenAconjugate_10dose_SII\/en\/. [Accessed 22 December 2016]."},{"issue":"9","key":"10.1016\/j.jinf.2017.04.007_bib18","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.4161\/hv.29678","article-title":"Meningitis caused by Neisseria meningitidis, Hemophilus influenzae type B and Streptococcus pneumoniae during 2005-2012 in Turkey. A multicenter prospective surveillance study","volume":"10","author":"Ceyhan","year":"2014","journal-title":"Hum Vaccin Immunother"},{"issue":"7","key":"10.1016\/j.jinf.2017.04.007_bib19","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.3201\/eid1407.070938","article-title":"A prospective study of etiology of childhood acute bacterial meningitis, Turkey","volume":"14","author":"Ceyhan","year":"2008","journal-title":"Emerg Infect Dis"},{"issue":"3","key":"10.1016\/j.jinf.2017.04.007_bib20","first-page":"98","article-title":"Meningococcal disease and control measures","volume":"15","author":"Kurugol","year":"2006","journal-title":"Turk Klin J Pediatr"},{"key":"10.1016\/j.jinf.2017.04.007_bib21","first-page":"32","article-title":"Epidemiology of meningococcal diseases: a study of 140 patients","volume":"27","author":"Tuysuz","year":"1992","journal-title":"Ist Cocuk Klin Derg"},{"issue":"11","key":"10.1016\/j.jinf.2017.04.007_bib22","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.1080\/21645515.2016.1209278","article-title":"Bacterial agents causing meningitis during 2013-2014 in Turkey: a multi-center hospital-based prospective surveillance study","volume":"12","author":"Ceyhan","year":"2016","journal-title":"Hum Vaccin Immunother"},{"issue":"41","key":"10.1016\/j.jinf.2017.04.007_bib23","doi-asserted-by":"crossref","first-page":"7233","DOI":"10.1016\/j.vaccine.2007.07.019","article-title":"Age-specific seroprevalence of serogroup C meningococcal serum bactericidal antibody activity and serogroup A, C, W135 and Y-specific IgG concentrations in the Turkish population during 2005","volume":"25","author":"Ceyhan","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.jinf.2017.04.007_bib24","first-page":"1","article-title":"The prevalence, serogroup distribution and risk factors of meningococcal carriage in adolescents and young adults in Turkey","author":"Tekin","year":"2017","journal-title":"Hum Vaccines Immunother"},{"issue":"5","key":"10.1016\/j.jinf.2017.04.007_bib25","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1586\/erv.12.29","article-title":"The dynamic and changing epidemiology of meningococcal disease at the country-based level: the experience in Turkey","volume":"11","author":"Dinleyici","year":"2012","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.jinf.2017.04.007_bib26","series-title":"Guidelines for the management, prevention and control of meningococcal disease in South Africa","author":"Department of Health, South Africa","year":"2011"},{"issue":"2","key":"10.1016\/j.jinf.2017.04.007_bib27","doi-asserted-by":"crossref","first-page":"273","DOI":"10.3201\/eid1302.051553","article-title":"Meningococcal disease in South Africa, 1999\u22122002","volume":"13","author":"Coulson","year":"2007","journal-title":"Emerg Infect Dis"},{"issue":"3","key":"10.1016\/j.jinf.2017.04.007_bib28","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1086\/525260","article-title":"Emergence of endemic serogroup W135 meningococcal disease associated with a high mortality rate in South Africa","volume":"46","author":"von Gottberg","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2017.04.007_bib29","series-title":"Presented at: Meningitis Research Foundation (MRF) Conference. Meningitis and septicaemia in children and adults","article-title":"Invasive meningococcal serogroup C and W disease in South Africa: 2003-2014. Poster E25","author":"Meiring","year":"2015"},{"issue":"9","key":"10.1016\/j.jinf.2017.04.007_bib30","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1097\/QAD.0b013e32833a2520","article-title":"Increased incidence of meningococcal disease in HIV-infected individuals associated with higher case-fatality ratios in South Africa","volume":"24","author":"Cohen","year":"2010","journal-title":"AIDS"},{"key":"10.1016\/j.jinf.2017.04.007_bib31","unstructured":"World Health Organization. Surveillance for vaccine preventable diseases (VPDs). WHO web site. Available at: http:\/\/www.who.int\/immunization\/monitoring_surveillance\/burden\/VPDs\/en\/. [Accessed 22 December 2016]."},{"issue":"1","key":"10.1016\/j.jinf.2017.04.007_bib32","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0163-4453(88)96117-8","article-title":"Meningococcal carriage, meningococcal disease and vaccination","volume":"16","author":"Hassan-King","year":"1988","journal-title":"J Infect"},{"issue":"9320","key":"10.1016\/j.jinf.2017.04.007_bib33","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1016\/S0140-6736(02)08679-8","article-title":"Carriage of serogroup C meningococci 1 year after meningococcal C conjugate polysaccharide vaccination","volume":"359","author":"Maiden","year":"2002","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.jinf.2017.04.007_bib34","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1093\/cid\/cis892","article-title":"Impact of the serogroup A meningococcal conjugate vaccine, MenAfriVac, on carriage and herd immunity","volume":"56","author":"Kristiansen","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"9911","key":"10.1016\/j.jinf.2017.04.007_bib35","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0140-6736(13)61612-8","article-title":"Effect of a serogroup A meningococcal conjugate vaccine (PsA-TT) on serogroup A meningococcal meningitis and carriage in Chad: a community study [corrected]","volume":"383","author":"Daugla","year":"2014","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.jinf.2017.04.007_bib36","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S1473-3099(10)70251-6","article-title":"Meningococcal carriage by age: a systematic review and meta-analysis","volume":"10","author":"Christensen","year":"2010","journal-title":"Lancet Infect Dis"},{"issue":"12","key":"10.1016\/j.jinf.2017.04.007_bib37","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S1473-3099(07)70288-8","article-title":"Meningococcal carriage in the African meningitis belt","volume":"7","author":"Trotter","year":"2007","journal-title":"Lancet Infect Dis"},{"issue":"Suppl 5","key":"10.1016\/j.jinf.2017.04.007_bib38","doi-asserted-by":"crossref","first-page":"S594","DOI":"10.1093\/cid\/civ508","article-title":"Modeling long-term vaccination strategies with MenAfriVac in the African meningitis belt","volume":"61","author":"Karachaliou","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.jinf.2017.04.007_bib39","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1093\/cid\/ciu881","article-title":"Increase in endemic Neisseria meningitidis capsular group W sequence type 11 complex associated with severe invasive disease in England and Wales","volume":"60","author":"Ladhani","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.jinf.2017.04.007_bib40","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.jinf.2016.06.010","article-title":"Early evidence of expanding W ST-11 CC meningococcal incidence in Spain","volume":"73","author":"Abad","year":"2016","journal-title":"J Infect"},{"issue":"5","key":"10.1016\/j.jinf.2017.04.007_bib41","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.jinf.2015.07.007","article-title":"Genomic resolution of an aggressive, widespread, diverse and expanding meningococcal serogroup B, C and W lineage","volume":"71","author":"Lucidarme","year":"2015","journal-title":"J Infect"},{"issue":"7","key":"10.1016\/j.jinf.2017.04.007_bib42","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1097\/INF.0b013e31828e9e91","article-title":"Invasive serogroup W meningococcal disease in children: a national survey from 2001 to 2008 in France","volume":"32","author":"Gaschignard","year":"2013","journal-title":"Pediatr Infect Dis J"},{"issue":"12","key":"10.1016\/j.jinf.2017.04.007_bib43","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2016.21.12.30175","article-title":"Presentation with gastrointestinal symptoms and high case fatality associated with group W meningococcal disease (MenW) in teenagers, England, July 2015 to January 2016","volume":"21","author":"Campbell","year":"2016","journal-title":"Euro Surveill"},{"issue":"9248","key":"10.1016\/j.jinf.2017.04.007_bib44","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1016\/S0140-6736(00)03502-9","article-title":"Serogroup W135 meningococcal disease in Hajj pilgrims","volume":"356","author":"Taha","year":"2000","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.jinf.2017.04.007_bib45","doi-asserted-by":"crossref","first-page":"2932","DOI":"10.1128\/IAI.73.5.2932-2939.2005","article-title":"Serologic responses to ACYW135 polysaccharide meningococcal vaccine in Saudi children under 5 years of age","volume":"73","author":"Al-Mazrou","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.jinf.2017.04.007_bib46","unstructured":"Departamento de Epidemiolog\u00eda. Informe vigilancia de enfermedad meningoc\u00f3cica. Departamento de Epidemiolog\u00eda. Available at: http:\/\/epi.minsal.cl\/enfermedad-meningococcica-vigilancia\/. [Accessed 3 March 2017]."},{"key":"10.1016\/j.jinf.2017.04.007_bib47","series-title":"Enfermedad meningoc\u00f3cica (CIE10:A39) situaci\u00f3n epidemiol\u00f3gica, Enero-Diciembre","author":"Departamento de Epidemiolog\u00eda","year":"2015"},{"issue":"1","key":"10.1016\/j.jinf.2017.04.007_bib48","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1136\/archdischild-2015-308928","article-title":"Enter B and W: two new meningococcal vaccine programmes launched","volume":"101","author":"Ladhani","year":"2016","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.jinf.2017.04.007_bib49","doi-asserted-by":"crossref","first-page":"g5725","DOI":"10.1136\/bmj.g5725","article-title":"Re-evaluating cost effectiveness of universal meningitis vaccination (Bexsero) in England: modelling study","volume":"349","author":"Christensen","year":"2014","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.jinf.2017.04.007_bib50","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.vaccine.2016.11.076","article-title":"Modelling the cost-effectiveness of catch-up 'MenB' (Bexsero) vaccination in England","volume":"35","author":"Christensen","year":"2017","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.jinf.2017.04.007_bib51","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1177\/0272989X05284109","article-title":"Reassessing the cost-effectiveness of meningococcal serogroup C conjugate (MCC) vaccines using a transmission dynamic model","volume":"26","author":"Trotter","year":"2006","journal-title":"Med Decis Mak"},{"key":"10.1016\/j.jinf.2017.04.007_bib52","unstructured":"World Health Organization. WHO position paper on meningococcal A conjugate vaccine. WHO web site. Available at: http:\/\/www.who.int\/immunization\/policy\/position_papers\/pp_menA_2015_presentation.pdf?ua=1. [Accessed 22 December 2016]."},{"issue":"13","key":"10.1016\/j.jinf.2017.04.007_bib53","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1016\/j.vaccine.2014.01.038","article-title":"Benefits of using vaccines out of the cold chain: delivering meningitis A vaccine in a controlled temperature chain during the mass immunization campaign in Benin","volume":"32","author":"Zipursky","year":"2014","journal-title":"Vaccine"},{"issue":"Suppl 5","key":"10.1016\/j.jinf.2017.04.007_bib54","doi-asserted-by":"crossref","first-page":"S570","DOI":"10.1093\/cid\/civ512","article-title":"MenAfriVac as an antitetanus vaccine","volume":"61","author":"Borrow","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.jinf.2017.04.007_bib55","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3201\/eid2003.131407","article-title":"Neisseria meningitidis serogroup W, Burkina Faso, 2012","volume":"20","author":"MacNeil","year":"2014","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.jinf.2017.04.007_bib56","article-title":"Invasive meningococcal meningitis serogroup C outbreak in northwest Nigeria, 2015-third consecutive outbreak of a new strain","volume":"8","author":"Chow","year":"2016","journal-title":"PLoS Curr"},{"issue":"10","key":"10.1016\/j.jinf.2017.04.007_bib57","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.3201\/eid2210.160468","article-title":"Whole-genome characterization of epidemic Neisseria meningitidis serogroup C and resurgence of serogroup W, Niger, 2015","volume":"22","author":"Kretz","year":"2016","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.jinf.2017.04.007_bib58","article-title":"Sequential outbreaks due to a new strain of Neisseria meningitidis serogroup C in northern Nigeria, 2013-14","volume":"6","author":"Funk","year":"2014","journal-title":"PLoS Curr"},{"key":"10.1016\/j.jinf.2017.04.007_bib59","unstructured":"Serum Institute of India. Product pipeline. Serum Institute of India. Available at: http:\/\/www.seruminstitute.com\/content\/prod_pipe.htm. [Accessed 25 January 2017]."},{"issue":"43","key":"10.1016\/j.jinf.2017.04.007_bib60","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.15585\/mmwr.mm6543a3","article-title":"Recommendations for use of meningococcal conjugate vaccines in HIV-infected persons - advisory Committee on Immunization Practices, 2016","volume":"65","author":"MacNeil","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"12","key":"10.1016\/j.jinf.2017.04.007_bib61","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1097\/00002030-199212000-00031","article-title":"Meningococcal meningitis and HIV infection: results from a case-control study in western Uganda","volume":"6","author":"Kipp","year":"1992","journal-title":"AIDS"},{"issue":"9","key":"10.1016\/j.jinf.2017.04.007_bib62","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1128\/jcm.30.9.2290-2294.1992","article-title":"Neisseria spp. and AIDS","volume":"30","author":"Morla","year":"1992","journal-title":"J Clin Microbiol"},{"issue":"4","key":"10.1016\/j.jinf.2017.04.007_bib63","first-page":"279","article-title":"Invasive meningococcal disease and HIV coinfection","volume":"25","author":"Couldwell","year":"2001","journal-title":"Commun Dis Intell Q Rep"},{"issue":"12","key":"10.1016\/j.jinf.2017.04.007_bib64","doi-asserted-by":"crossref","first-page":"937","DOI":"10.7326\/0003-4819-123-12-199512150-00007","article-title":"Sporadic meningococcal disease in adults: results of a 5-year population-based study","volume":"123","author":"Stephens","year":"1995","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.jinf.2017.04.007_bib65","doi-asserted-by":"crossref","first-page":"30","DOI":"10.7326\/0003-4819-160-1-201401070-00731","article-title":"Elevated risk for invasive meningococcal disease among persons with HIV","volume":"160","author":"Miller","year":"2014","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.jinf.2017.04.007_bib66","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/INF.0b013e318236c67b","article-title":"Safety and immunogenicity of quadrivalent meningococcal conjugate vaccine in 2- to 10-year-old human immunodeficiency virus-infected children","volume":"31","author":"Siberry","year":"2012","journal-title":"Pediatr Infect Dis J"},{"issue":"5","key":"10.1016\/j.jinf.2017.04.007_bib67","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1097\/INF.0b013e3181c38f3b","article-title":"Phase I\/II, open-label trial of safety and immunogenicity of meningococcal (groups A, C, Y, and W-135) polysaccharide diphtheria toxoid conjugate vaccine in human immunodeficiency virus-infected adolescents","volume":"29","author":"Siberry","year":"2010","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jinf.2017.04.007_bib68","series-title":"British HIV Association guidelines on the use of vaccines in HIV-positive adults","author":"British HIV Association","year":"2015"},{"issue":"5","key":"10.1016\/j.jinf.2017.04.007_bib69","doi-asserted-by":"crossref","first-page":"e0154047","DOI":"10.1371\/journal.pone.0154047","article-title":"Evolutionary events associated with an outbreak of meningococcal disease in men who have sex with men","volume":"11","author":"Taha","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jinf.2017.04.007_bib70","unstructured":"Advocacy for Immunization. Welcome to advocacy for immunisation. Advocacy for Immunization. Available at: http:\/\/advocacy.vaccineswork.org\/. [Accessed 22 December 2016]."},{"key":"10.1016\/j.jinf.2017.04.007_bib71","unstructured":"Meningitis Now. Meningis Now web site. Available at: https:\/\/www.meningitisnow.org\/. [Accessed 22 December 2016]."}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445317301147?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445317301147?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T21:23:52Z","timestamp":1759008232000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445317301147"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":71,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["S0163445317301147"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2017.04.007","relation":{},"ISSN":["0163-4453"],"issn-type":[{"value":"0163-4453","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Meningococcal disease in the Middle East and Africa: Findings and updates from the Global Meningococcal Initiative","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2017.04.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier Ltd on behalf of The British Infection Association.","name":"copyright","label":"Copyright"}]}}